Stock Scorecard
Stock Summary for Ensysce Biosciences Inc (ENSC) - $2.47 as of 5/5/2025 11:08:31 PM EST
Total Score
12 out of 30
Safety Score
26 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ENSC
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ENSC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ENSC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ENSC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ENSC (26 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 6 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 3 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ENSC
Financial Details for ENSC
Company Overview |
|
|---|---|
| Ticker | ENSC |
| Company Name | Ensysce Biosciences Inc |
| Country | USA |
| Description | Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. The company is headquartered in La Jolla, California. |
| Sector Name | REAL ESTATE & CONSTRUCTION |
| Industry Name | BLANK CHECKS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 5/12/2025 |
Stock Price History |
|
| Last Day Price | 2.47 |
| Price 4 Years Ago | 16,920.00 |
| Last Day Price Updated | 5/5/2025 11:08:31 PM EST |
| Last Day Volume | 75,624 |
| Average Daily Volume | 3,285,070 |
| 52-Week High | 14.67 |
| 52-Week Low | 1.62 |
| Last Price to 52 Week Low | 52.47% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 106.32 |
| Sector PE | 67.58 |
| 5-Year Average PE | -357.60 |
| Free Cash Flow Ratio | 1.16 |
| Industry Free Cash Flow Ratio | 122.52 |
| Sector Free Cash Flow Ratio | 88.37 |
| Current Ratio Most Recent Quarter | 2.42 |
| Total Cash Per Share | 2.13 |
| Book Value Per Share Most Recent Quarter | 2.74 |
| Price to Book Ratio | 1.32 |
| Industry Price to Book Ratio | 3.86 |
| Sector Price to Book Ratio | 12.18 |
| Price to Sales Ratio Twelve Trailing Months | 0.81 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.15 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.47 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 1,644,700 |
| Market Capitalization | 4,062,409 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -75,258,255.87% |
| Reported EPS 12 Trailing Months | -11.45 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -3.60 |
| Net Income Twelve Trailing Months | -7,986,935 |
| Net Income Past Year | -7,987,225,000,000 |
| Net Income Prior Year | -10,613,074 |
| Quarterly Revenue Growth YOY | 153.10% |
| 5-Year Revenue Growth | -100.00% |
| Operating Margin Twelve Trailing Months | -274.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 3,502,077 |
| Total Cash Past Year | 3,502,077 |
| Total Cash Prior Year | 1,123,604 |
| Net Cash Position Most Recent Quarter | 3,114,901 |
| Net Cash Position Past Year | 2,647,380 |
| Long Term Debt Past Year | 854,697 |
| Long Term Debt Prior Year | 4,717,104 |
| Total Debt Most Recent Quarter | 387,176 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 0.91 |
| Total Stockholder Equity Past Year | 3,708,422,000,000 |
| Total Stockholder Equity Prior Year | -322,858 |
| Total Stockholder Equity Most Recent Quarter | 3,708,422 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -7,502,700 |
| Free Cash Flow Per Share Twelve Trailing Months | -4.56 |
| Free Cash Flow Past Year | -7,502,700,000,000 |
| Free Cash Flow Prior Year | -10,779,984 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.12 |
| MACD Signal | -0.24 |
| 20-Day Bollinger Lower Band | 0.40 |
| 20-Day Bollinger Middle Band | 5.03 |
| 20-Day Bollinger Upper Band | 9.66 |
| Beta | 1.07 |
| RSI | 44.97 |
| 50-Day SMA | 219.67 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 2,478.18 |
System |
|
| Modified | 5/5/2025 11:09:17 PM EST |